Year |
Citation |
Score |
2023 |
El Kamouni H, S Jalaledin D, Albert A, Hoa S, Vo C, Bourré-Tessier J, Rich É, Goulet JR, Koenig M, Pérez G, Choi MY, Troyanov Y, Satoh M, Fritzler MJ, Senécal JL, et al. Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype. Rmd Open. 9. PMID 37797966 DOI: 10.1136/rmdopen-2023-003431 |
0.321 |
|
2020 |
Landon-Cardinal O, Baril-Dionne A, Hoa S, Meyer A, Leclair V, Bourré-Tessier J, Mansour AM, Zarka F, Makhzoum JP, Nehme J, Rich E, Goulet JR, Grodzicky T, Koenig M, Joyal F, et al. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. Rmd Open. 6. PMID 32892170 DOI: 10.1136/Rmdopen-2020-001357 |
0.455 |
|
2020 |
Meyer A, Troyanov Y, Drouin J, Oligny-Longpré G, Landon-Cardinal O, Hoa S, Hervier B, Bourré-Tessier J, Mansour AM, Hussein S, Morin V, Rich E, Goulet JR, Chartrand S, Hudson M, et al. Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients. Arthritis Research & Therapy. 22: 5. PMID 31915059 DOI: 10.1186/S13075-019-2093-6 |
0.376 |
|
2019 |
Senécal JL, Hoa S, Yang R, Koenig M. Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis. Journal of Scleroderma and Related Disorders. 5: 103-129. PMID 35382028 DOI: 10.1177/2397198319870667 |
0.357 |
|
2019 |
Koenig M, Bentow C, Satoh M, Fritzler MJ, Senécal JL, Mahler M. Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype. Rheumatology (Oxford, England). PMID 31323671 DOI: 10.1093/Rheumatology/Kez123 |
0.443 |
|
2017 |
Koenig M, Senécal JL, Mahler M. Seroconversion from Anti-Th/To to Anticentromere Antibodies in a Patient with Systemic Sclerosis. The Journal of Rheumatology. 44: 1938-1939. PMID 29196548 DOI: 10.3899/Jrheum.170575 |
0.476 |
|
2017 |
Mehta H, Goulet PO, Mashiko S, Desjardins J, Pérez G, Koenig M, Senécal JL, Constante M, Santos MM, Sarfati M. Early life antibiotic exposure causes intestinal dysbiosis and exacerbates skin and lung pathology in experimental systemic sclerosis. The Journal of Investigative Dermatology. PMID 28757138 DOI: 10.1016/J.Jid.2017.06.019 |
0.303 |
|
2017 |
Troyanov Y, Landon-Cardinal O, Fritzler MJ, Ferreira J, Targoff IN, Rich E, Goulet M, Goulet JR, Bourré-Tessier J, Robitaille Y, Drouin J, Albert A, Senécal JL. Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Medicine. 96: e5694. PMID 28099331 DOI: 10.1097/Md.0000000000005694 |
0.337 |
|
2015 |
Hoa S, Chartrand S, Troyanov Y, Mansour A, Rich E, Boudabbouz H, Bourré-Tessier J, Landry M, Albert M, Senécal J, Fritzler M, Targoff I. The Anti-MDA5 Phenotype: Defining Clinical, Biochemical, and Radiological Features Suggestive of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease Chest. 148: 866A. DOI: 10.1378/Chest.2262512 |
0.36 |
|
2014 |
Bernatsky S, Ramsey-Goldman R, Boivin J, Joseph L, Petri MA, Zoma A, Manzi S, Urowitz MB, Gladman DD, Fortin PR, Ginzler EM, Yelin E, Bae S, Wallace DJ, Edworthy SM, et al. Cancer risk factors in systemic lupus erythematosus: multivariate regression analysis in 16,409 patients Arthritis Research & Therapy. 16: A35. DOI: 10.1186/Ar4651 |
0.321 |
|
2012 |
Arcand J, Robitaille G, Koenig M, Senécal JL, Raymond Y. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts. Arthritis and Rheumatism. 64: 1632-41. PMID 22095242 DOI: 10.1002/Art.33484 |
0.648 |
|
2012 |
Arcand J, Robitaille G, Koenig M, Senécal JL, Raymond Y. The autoantigen DNA topoisomerase I interacts with chemokine receptor 7 and exerts cytokine-like effects on dermal fibroblasts. Arthritis and Rheumatism. 64: 826-34. PMID 21953548 DOI: 10.1002/Art.33377 |
0.623 |
|
2009 |
Robitaille G, Christin MS, Clément I, Senécal JL, Raymond Y. Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells. Arthritis and Rheumatism. 60: 2805-16. PMID 19714638 DOI: 10.1002/Art.24765 |
0.365 |
|
2008 |
Koenig M, Dieudé M, Senécal JL. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmunity Reviews. 7: 588-93. PMID 18617021 DOI: 10.1016/J.Autrev.2008.06.010 |
0.661 |
|
2007 |
Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senécal JL. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Research & Therapy. 9: R78. PMID 17688695 DOI: 10.1186/Ar2276 |
0.471 |
|
2007 |
Chabaud S, Boufaied I, Corriveau M, Grodzicky T, Senecal J, Moulin V. Apoptosis plays a key role in clonal selection of pathologic fibroblast sub‐populations in systemic sclerosis The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A13-B |
0.316 |
|
2006 |
Hénault J, Robitaille G, Senécal JL, Raymond Y. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis and Rheumatism. 54: 963-73. PMID 16508979 DOI: 10.1002/Art.21646 |
0.521 |
|
2004 |
Dieudé M, Senécal JL, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis and Rheumatism. 50: 3221-31. PMID 15476243 DOI: 10.1002/Art.20564 |
0.672 |
|
2004 |
Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis and Rheumatism. 50: 3265-74. PMID 15476238 DOI: 10.1002/Art.20515 |
0.533 |
|
2002 |
Dieudé M, Senécal JL, Rauch J, Hanly JG, Fortin P, Brassard N, Raymond Y. Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: lack of evidence for a direct role of lamin B1 in apoptotic blebs. Arthritis and Rheumatism. 46: 2695-707. PMID 12384929 DOI: 10.1002/Art.10552 |
0.684 |
|
2002 |
Dagher JH, Scheer U, Voit R, Grummt I, Lonzetti L, Raymond Y, Senécal JL. Autoantibodies to NOR 90/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response. The Journal of Rheumatology. 29: 1543-7. PMID 12136917 |
0.358 |
|
2001 |
Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis and Rheumatism. 44: 2331-7. PMID 11665973 DOI: 10.1002/1529-0131(200110)44:10<2331::Aid-Art395>3.0.Co;2-I |
0.314 |
|
1999 |
Gavanescu I, Vazquez-Abad D, McCauley J, Senecal JL, Doxsey S. Centrosome proteins: a major class of autoantigens in scleroderma. Journal of Clinical Immunology. 19: 166-71. PMID 10404401 DOI: 10.1023/A:1020551610319 |
0.453 |
|
1999 |
Vázquez-Abad D, Grodzicky T, Senécal J. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis. Clinical Immunology. 90: 182-189. PMID 10080829 DOI: 10.1006/Clim.1998.4643 |
0.392 |
|
1996 |
Uthman I, Vazquez-Abad D, Senecal JL. Distinctive features of idiopathic inflammatory myopathies in French Canadians Seminars in Arthritis and Rheumatism. 26: 447-458. PMID 8870112 DOI: 10.1016/S0049-0172(96)80025-4 |
0.421 |
|
1996 |
Lenert P, Lenert G, Senécal J. CD4-reactive antibodies in systemic lupus erythematosus. Human Immunology. 49: 38-48. PMID 8839774 DOI: 10.1016/0198-8859(96)00058-4 |
0.35 |
|
1996 |
Rivest C, Miller FW, Love LA, Turgeon P, Blier C, Senécal J. Focal myositis presenting as pseudothrombophlebitis of the neck in a patient with mixed connective tissue disease Arthritis & Rheumatism. 39: 1254-1258. PMID 8670340 DOI: 10.1002/Art.1780390728 |
0.328 |
|
1996 |
Senecal JL. Subcutaneous calcinosis in systemic sclerosis Arthritis and Rheumatism. 39: 796. DOI: 10.1002/Art.1780390512 |
0.327 |
|
1995 |
Senécal JL, Chartier S, Rothfield N. Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine. The Journal of Rheumatology. 22: 868-75. PMID 8587074 |
0.344 |
|
1995 |
Fritzler MJ, Hart DA, Wilson D, Garcia-De la Torre I, Salazar-Paramo M, Vazquez-Del Mercado M, Senecal JL, Loyau S, Angles-Cano E. Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis Journal of Rheumatology. 22: 1688-1693. PMID 8523346 |
0.358 |
|
1995 |
Girard D, Senecal JL. Anti-microfilament IgG antibodies in normal adults and in patients with autoimmune diseases: Immunofluorescence and immunoblotting analysis of 201 subjects reveals polyreactivity with microfilament-associated proteins Clinical Immunology and Immunopathology. 74: 193-201. PMID 7828374 DOI: 10.1006/Clin.1995.1028 |
0.44 |
|
1995 |
Girard D, Raymond Y, Labbé P, Senécal JL. Characterization of a novel human antibody xenoreactive with fibronectin. Clinical Immunology and Immunopathology. 77: 149-61. PMID 7586722 DOI: 10.1006/Clin.1995.1138 |
0.408 |
|
1995 |
Girard D, Senécal JL. Characterization of a novel human igg antibody reactive with a ca2+-sensitive cell-cell adhesion epitope of ptk2 epithelial cells Autoimmunity. 20: 237-245. PMID 7578886 DOI: 10.3109/08916939508995701 |
0.38 |
|
1994 |
Ayer LM, Sénecal JL, Martin L, Dixon GH, Fritzler MJ. Antibodies to high mobility group proteins in systemic sclerosis. The Journal of Rheumatology. 21: 2071-5. PMID 7869312 |
0.306 |
|
1992 |
Senécal JL, Raymond Y. Autoantibodies to major and minor nuclear lamins are not restricted to autoimmune diseases Clinical Immunology and Immunopathology. 63: 115-125. PMID 1611714 DOI: 10.1016/0090-1229(92)90003-7 |
0.457 |
|
1991 |
Senecal JL, Raymnd Y. Autoantibodies to DNA, lamins, and pore complex proteins produce distinct peripheral fluorescent antinuclear antibody patterns on the HEp-2 substrate [8] Arthritis and Rheumatism. 34: 249-251. PMID 1994930 DOI: 10.1002/Art.1780340226 |
0.354 |
|
1991 |
Weiner ES, Hildebrandt S, Senécal JL, Daniels L, Noell S, Joyal F, Roussin A, Earnshaw W, Rothfield NF. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis and Rheumatism. 34: 68-77. PMID 1845841 DOI: 10.1002/Art.1780340111 |
0.46 |
|
1990 |
Hildebrandt S, Weiner ES, Senecal JL, Noell GS, Earnshaw WC, Rothfield NF. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay. Clinical Immunology and Immunopathology. 57: 399-410. PMID 2173985 DOI: 10.1016/0090-1229(90)90114-6 |
0.392 |
|
1988 |
Dagenais A, Bibor‐Hardy V, Senécal J. A novel autoantibody causing a peripheral fluorescent antinuclear antibody pattern is specific for nuclear pore complexes Arthritis & Rheumatism. 31: 1322-1327. PMID 3052460 DOI: 10.1002/Art.1780311017 |
0.37 |
|
1985 |
Senecal JL, Oliver JM, Rothfield N. Anticytoskeletal autoantibodies in the connective tissue diseases Arthritis and Rheumatism. 28: 889-898. PMID 4040759 DOI: 10.1002/Art.1780280808 |
0.461 |
|
1984 |
Tramposch HD, Smith CD, Senecal J, Rothfield N. A long-term longitudinal study of anticentromere antibodies. Arthritis & Rheumatism. 27: 121-124. PMID 6607733 DOI: 10.1002/Art.1780270201 |
0.4 |
|
Show low-probability matches. |